We have isolated peak II, which is the peak of the middle molecules containing polyamines, from dialysate of uremic patients in recirculating dialysis. We investigated the effect of total dialysate, chromatographic peaks, I, II, III, IV and commercial polyamines on polymorphonuclear leukocyte chemotaxis and superoxide production (i.e. phagocytic activity) in healthy and uremic patients. Polymorphonuclear chemotaxis was inhibited by total dialysate and peak II but not by polyamines; polyamines, total dialysate and peak II had no activity on polymorphonuclear phagocytosis.
GreeneW.H., CasannR.S., MauerM., QuieP.E.The effect of hemodialysis on neutrophil chemotactic responsiveness.J Lab Clin Med1976; 88: 971–3.
3.
BaumJ., CesteroR.U.M., FreemanB.R.Chemotaxis of the polymorphonuclear leukocyte and delayed hypersensitivity in uremia.Kidney International, 7 (Suppl. 2): 147–53.
4.
RingoirS.M.G., van LandschootN., de SmetR.Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate.Clin Nephrol1980; 13: 109–12.
5.
OdebergH., OlssonI., ThysellH.The effect of uremic serum on granulocyte iodination capacity.Trans Am Soc Artif Intern Organs1973; 419: 484–6.
6.
BergstroemJ., FuerstP.Uremic toxins. Comptes rendu - VII Congrès Int Néprol Karger S, Base, 1978: 669–74.
7.
KjellestrandC.M.Inadequacy of dialysis: why patients are not well.Trans Am Soc Artif Intern Organs1979; 25: 518–20.
8.
FuerstP., ZimmermannL., BergstroemJ.Determination of endogenous middle molecules in normal and uremic body fluids.Clin Nephrol1976; 5: 178–88.
9.
WilkinsonP.C.Outline a method for measuring chemotaxis. In: WilkinsonP.C. ed. Chemotaxis and inflammation, Edinburgh: Churchill-Livingstone, 1974; 168–72.
10.
SpisaniS., TranielloS.Effect of mediator of inflammation on human neutrophil motility. In: WeissmanG., SamuelssonB., PaolettiR. eds. Advances in inflammation research, New YorkRaven Press, 1979; 237–45.
11.
ZigmondS.H., HirshJ.G.Leukocyte locomotion and chemotaxis: New method for evaluation and demonstration of a cell derived chemotactic factor.J Exp Med1973; 137: 387–410.
12.
SpisaniS., MarangoniC., TranielloS.Effect of antiinflammatory agents on neutrophil superoxide production on rheumatoid arthritis.Inflammation,1984; 8: 45–52.
13.
SoborgM., BendixenC.Human lymphocytes migration as a parameter of hypersensitivity.Acta Med Scand1967; 181: 247–51.
14.
SealeT.W., ChanW.Y., ShulkaJ., RennertO.M.A polyamine coniugated peptide isolated from human plasma.Arch Biochem Biophys1979; 198: 164–74.
15.
StabelliniG., FiocchiO., GilliP., SquerzantiR., TataranniG., FarinelliA.Comportamento delle poliamine alifatiche endogene durante emodialisi con membrane a diversa permeabilità (cuprophan e poliacrilonitrile AN 69).Atti Incontro Hospal sul PAN1980; 69: 15–20.
16.
StabelliniG., SpisaniS., FiocchiO.Tossine uremiche mediomolecolari e poliamine endogene.Comportamento della chemiotassi dei polimorfonucleati rispetto ai picchi cromatografici di dialisato e poliamine standard, Boll Soc Ital Biol Sper1982; 58: 1418–24.
